Chapman patent opposition analysis

The comprehensive analysis of Chapman opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Chapman

Patent NumberTitleApplicantOpposition DateOpposition Company
Methods For Cell Expansion And Uses Of Cells And Conditioned Media Produced Thereby For TherapyPLURISTEMJun 2, 2020STRAWMAN
Pluripotent Stem Cell Derived From Cardiac TissueKYOTO UNIVERSITYJan 27, 2017STRAWMAN
Monoclonal Antibodies Having Homosubtype Cross -Neutralization Properties Against Influenza A Viruses Subtype H1POMONA RICERCAJun 9, 2016JAMES POOLE

Top companies who are the clients of Chapman

CompanyTotal
STRAWMAN2
JAMES POOLE1